SCHEMBL14765250

SCHEMBL14765250

c1csc(-c2nc(-c3ccncc3)cs2)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.73
RAB9A P51151 9/20 0.73
KMT2A Q03164 5/20 0.73
MEN1 O00255 4/20 0.73
MAPT P10636 3/20 0.73
HPGD P15428 1/20 0.73
CASP3 P42574 1/20 0.73
SENP8 Q96LD8 1/20 0.73
SENP7 Q9BQF6 1/20 0.73
SENP6 Q9GZR1 1/20 0.73
TDP1 Q9NUW8 1/20 0.73
L3MBTL1 Q9Y468 1/20 0.73
AR P10275 2/20 0.64
CYP19A1 P11511 4/20 0.62
MAPK1 P28482 1/20 0.60
HSD17B10 Q99714 1/20 0.60
SMN1; SMN2 Q16637 6/20 0.58
NPC1 O15118 6/20 0.58
ALDH1A1 P00352 2/20 0.58
HTT P42858 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27894128 0.98 KDM4E (0.71) KDM4ERAB9AKMT2AMEN1MAPT
SCHEMBL10625602 0.89 KDM4E (0.73) KDM4ERAB9AKMT2AMEN1MAPT
SCHEMBL27935903 0.85 KDM4E (1.00) KDM4ERAB9AKMT2AMEN1MAPT
SCHEMBL10715489 0.85 RAB9A (0.67) KDM4ERAB9AKMT2AMEN1MAPT
SCHEMBL23657508 0.79 KDM4E (0.58) KDM4ERAB9AKMT2AMEN1MAPT
SCHEMBL12046059 0.78 KDM4E (0.67) KDM4ERAB9AKMT2AMEN1MAPT
SCHEMBL68135 0.78 KDM4E (1.00) KDM4ERAB9AKMT2AMEN1MAPT
SCHEMBL13480645 0.78 KDM4E (1.00) KDM4ERAB9AKMT2AMEN1MAPT
SCHEMBL17336954 0.78 KDM4E (0.61) KDM4ERAB9AKMT2AMEN1MAPT
SCHEMBL6197194 0.78 KDM4E (0.67) KDM4ERAB9AKMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2753620-B1 NOVEL PROCESS FOR PREPARING CEFTAROLINE FOSAMIL SANDOZ AG (CH) 2017-02-15 EP claimed
US-20160009745-A1 NOVEL PROCESS FOR PREPARING CEFTAROLINE FOSAMIL SANDOZ AG (CH) 2016-01-14 US claimed
US-9169239-B2 Process for preparing ceftaroline fosamil SANDOZ AG (CH) 2015-10-27 US claimed
US-20150073138-A1 NOVEL PROCESS FOR PREPARING CEFTAROLINE FOSAMIL SANDOZ AG (CH) 2015-03-12 US claimed
WO-2013034718-A1 NOVEL PROCESS FOR PREPARING CEFTAROLINE FOSAMIL SANDOZ AG (CH) 2013-03-14 WO claimed
EP-2753620-B1 NOVEL PROCESS FOR PREPARING CEFTAROLINE FOSAMIL SANDOZ AG (CH) 2017-02-15 EP disclosed
US-9382278-B2 Process for preparing ceftaroline fosamil SANDOZ AG (CH) 2016-07-05 US disclosed
US-20160009745-A1 NOVEL PROCESS FOR PREPARING CEFTAROLINE FOSAMIL SANDOZ AG (CH) 2016-01-14 US disclosed
US-9169239-B2 Process for preparing ceftaroline fosamil SANDOZ AG (CH) 2015-10-27 US disclosed
US-20150073138-A1 NOVEL PROCESS FOR PREPARING CEFTAROLINE FOSAMIL SANDOZ AG (CH) 2015-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150073138-A1 NOVEL PROCESS FOR PREPARING CEFTAROLINE FOSAMIL FOS, FOSB, CYP3A7 KDM4E 1419/4885RAB9A 1527/4885KMT2A 1230/4885
US-20160009745-A1 NOVEL PROCESS FOR PREPARING CEFTAROLINE FOSAMIL FOS, FOSB, CYP3A7 KDM4E 758/4885RAB9A 767/4885KMT2A 1544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.